Kabra Drugs Ltd board meeting on May 29, 2026 to approve Q4 FY26 unaudited financial results.
Meeting to be held at company's corporate office in Chennai pursuant to SEBI LODR regulations.
Trading window closed for insiders until 48 hours after results announcement.
Disclosure made under Regulation 29 of SEBI Listing Obligations.